Lasertherapy as A Strategy for Treatment Healing under Caloric Restriction – Study in Rats
Journal: Journal of Pharmacy and Pharmacology (Vol.6, No. 7)Publication Date: 2018-07-07
Authors : Leandro C. Moscardi; Talita P. Espíndola; Amanda A. Ferreira; et al;
Page : 647-658
Keywords : ;
Abstract
Complications in the healing process are challenging, especially in clinical situations of caloric restriction (CR). The lasertherapy becomes an important strategy that aids the repair, especially in CR. Thus, it is important to investigate the InGaAlP-660 nm laser as an strategy to repair cutaneous wounds in rats submitted to 30% of CR and to understand the tissue repair in clinical situations of CR. Thirty-six male Wistar rats were used, of which half were fed with 30% less ration, and half with ad libitum diet, for 21 days. Then, punch lesions of 1.5 cm in diameter were made on the animals backs, which were divided into: NR (no-restricted), R (restricted)—both before lesion; C (control), RC (restricted-control), L (laser), RL (restricted-laser)—after lesion. Samples of the skin/lesion/scar were collected on the 2nd, 7th and 14th days post-injury for histological, biochemical and molecular analyses. The R group showed reduction of body mass, epidermal/dermal thickness, inflammation, angiogenesis, fibroplasia and collagenesis. The RL group showed control of inflammation, oxidative damage and increase of antioxidants than RC, which probably favored angiogenesis, collagenesis and reepithelialization, similar to C and L. Thus, 30% of CR impaired the skin (before lesion). In the lesion, lasertherapy has shown to be effective in tissue repair mainly in CR status, being thus, the laser clinically important strategy to tissue repair in critical situations of caloric restriction.
Other Latest Articles
- Electromagnetic Stimulation Combined with Aloe vera Increases Collagen Reorganization in Burn Repair
- Association of HbA1c Level with Lipid Ratio in Diabetic Patients
- Investigation of the Mutagenic Potential of Immunomodulator Arglabin Native in Tablets in the Ames Test
- Development and Validation of Proximal Chemistry Analytical Procedure in Semi-automated Equipment
- Sanitary Regulation of Pharmaceutical Products in Mexico (Sanitary Registration-Board Arrangement-Patent)—Monoclonal Antibody Case Study
Last modified: 2022-06-28 10:21:16